Ascletis Pharma Stock Market Value
| ASCLF Stock | USD 1.78 0.25 16.34% |
| Symbol | Ascletis |
Ascletis Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Ascletis Pharma's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Ascletis Pharma.
| 12/20/2025 |
| 01/19/2026 |
If you would invest 0.00 in Ascletis Pharma on December 20, 2025 and sell it all today you would earn a total of 0.00 from holding Ascletis Pharma or generate 0.0% return on investment in Ascletis Pharma over 30 days. Ascletis Pharma is related to or competes with SanBio Company, CStone Pharmaceuticals, Pharming Group, Idorsia, SSY Group, Biogaia AB, and Tobii Dynavox. Ascletis Pharma Inc., a biotechnology company, engages in the research and development, manufacture, marketing, and sale... More
Ascletis Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Ascletis Pharma's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Ascletis Pharma upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 11.71 | |||
| Information Ratio | 0.1115 | |||
| Maximum Drawdown | 52.45 | |||
| Value At Risk | (4.92) | |||
| Potential Upside | 12.11 |
Ascletis Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ascletis Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Ascletis Pharma's standard deviation. In reality, there are many statistical measures that can use Ascletis Pharma historical prices to predict the future Ascletis Pharma's volatility.| Risk Adjusted Performance | 0.0966 | |||
| Jensen Alpha | 0.7727 | |||
| Total Risk Alpha | (0.04) | |||
| Sortino Ratio | 0.0635 | |||
| Treynor Ratio | 1.22 |
Ascletis Pharma Backtested Returns
Ascletis Pharma appears to be dangerous, given 3 months investment horizon. Ascletis Pharma secures Sharpe Ratio (or Efficiency) of 0.12, which signifies that the company had a 0.12 % return per unit of standard deviation over the last 3 months. By analyzing Ascletis Pharma's technical indicators, you can evaluate if the expected return of 0.82% is justified by implied risk. Please makes use of Ascletis Pharma's mean deviation of 3.32, and Risk Adjusted Performance of 0.0966 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Ascletis Pharma holds a performance score of 9. The firm shows a Beta (market volatility) of 0.68, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Ascletis Pharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Ascletis Pharma is expected to be smaller as well. Please check Ascletis Pharma's sortino ratio, semi variance, and the relationship between the information ratio and value at risk , to make a quick decision on whether Ascletis Pharma's price patterns will revert.
Auto-correlation | -0.62 |
Very good reverse predictability
Ascletis Pharma has very good reverse predictability. Overlapping area represents the amount of predictability between Ascletis Pharma time series from 20th of December 2025 to 4th of January 2026 and 4th of January 2026 to 19th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Ascletis Pharma price movement. The serial correlation of -0.62 indicates that roughly 62.0% of current Ascletis Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.62 | |
| Spearman Rank Test | -0.26 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Ascletis Pharma lagged returns against current returns
Autocorrelation, which is Ascletis Pharma pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Ascletis Pharma's pink sheet expected returns. We can calculate the autocorrelation of Ascletis Pharma returns to help us make a trade decision. For example, suppose you find that Ascletis Pharma has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Ascletis Pharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Ascletis Pharma pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Ascletis Pharma pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Ascletis Pharma pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Ascletis Pharma Lagged Returns
When evaluating Ascletis Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Ascletis Pharma pink sheet have on its future price. Ascletis Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Ascletis Pharma autocorrelation shows the relationship between Ascletis Pharma pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Ascletis Pharma.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Ascletis Pink Sheet
Ascletis Pharma financial ratios help investors to determine whether Ascletis Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ascletis with respect to the benefits of owning Ascletis Pharma security.